BioSpace News Archive

IMS Reports the Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Using JCI MN Colloidal Iodine

Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, lectured about multidisciplinary approaches which are getting remarkable effect to minimally invasive cancer treatment using JCI MN Colloidal Iodine.

September 6, 2019
·
5 min read
Policy

/R E P E A T -- Media Advisory - Minister Ng to highlight investments to scale up Canadian health technology companies/

The Honourable Mary Ng, Minister of Small Business and Export Promotion, will attend the Toronto Global Forum, where she will highlight investments to scale up Canadian health technology companies.

September 6, 2019
·
1 min read
BioCapital

29 Million Depend on Primary Care Funding that Expires September 30

In a matter of days, every health center in America stands to lose more than 70% of their federal grant funding without Congress extending the funding by September 30.

September 6, 2019
·
2 min read
Biotech Bay

Kodiak Sciences to Present at the Morgan Stanley Global Healthcare Conference

Kodiak Sciences Inc. announced that management will participate in the Morgan Stanley Global Healthcare Conference in New York, NY on Monday, September 9 at 4:50 p.m. Eastern Time.

September 6, 2019
·
1 min read
Policy

Occlutech AFR Heart Failure Device Obtains CE Mark Approval

Occlutech AG announced that its atrial flow regulator, the Occlutech AFR device, has obtained CE mark approval clearing it for sales on the European CE regulated market.

September 6, 2019
·
2 min read
Deals

Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference

Aurinia Pharmaceuticals Inc. announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will present a corporate overview at the 21st Annual H.C. Wainwright Global Investment Conference on Monday, September 9, 2019 at 12:30pm ET in New York, NY.

September 6, 2019
·
1 min read
Genetown

42 North Dental Adds Three Affiliated Practices in Massachusetts

Locations in Westborough, Watertown, and Cambridge

September 6, 2019
·
2 min read
Deals

Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes

Invitae Corporation announced the pricing on September 5, 2019 of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

September 6, 2019
·
5 min read
BioCapital

Viela Bio Announces Publication in The Lancet of Pivotal Study Results of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder

Viela Bio announced that peer-reviewed journal, The Lancet, has published results from its pivotal study of inebilizumab in patients with neuromyelitis optica spectrum disorder.

September 6, 2019
·
6 min read
BioForest

Omeros to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Omeros Corporation announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the H.C. Wainwright 21st Annual Global Investment Conference in New York next week.

September 6, 2019
·
1 min read